BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34945006)

  • 1. Preface of the Special Issue: "Peritoneal Surface Malignancies (PSM): The SICO (Italian Society of Surgical Oncology) PSM-Oncoteam Experience, Result Analysis, and Studies' Purpose".
    Sammartino P; Vaira M
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34945006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant systemic treatment for breast cancer in Italy: The Italian Society of Surgical Oncology (SICO) Breast Oncoteam survey.
    Vicini E; Invento A; Cuoghi M; Bafile A; Battaglia C; Biglia N; Busani M; Bussone R; Cianchetti E; Caruso F; Cucchi MC; Dessena M; Di Filippo F; Fabi N; Folli S; Friedman D; Macellari G; Mainente P; Murgo R; Neri A; Pollini GP; Palli D; Ricci F; Scalco G; Taffurelli M; Trunfio M; Galimberti V;
    Eur J Surg Oncol; 2018 Aug; 44(8):1157-1163. PubMed ID: 29653781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer.
    Cavaliere D; Cirocchi R; Coccolini F; Fagotti A; Fambrini M; Federici O; Lorusso D; Vaira M; Ceresoli M; Delrio P; Garofalo A; Pignata S; Scollo P; Trojano V; Amadori A; Ansaloni L; Cariti G; De Cian F; De Iaco P; De Simone M; Deraco M; Donini A; Fiorentini G; Frigerio L; Greggi S; Macrì A; Pasqual EM; Roviello F; Sammartino P; Sassaroli C; Scambia G; Staudacher C; Vici P; Vizza E; Valle M; ; ; ;
    Tumori; 2017 Nov; 103(6):525-536. PubMed ID: 28430350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of peritoneal cancer index for survival in patients with mucinous peritoneal malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience.
    Brandl A; Weiss S; von Winterfeld M; Krannich A; Feist M; Pratschke J; Raue W; Rau B
    Int J Hyperthermia; 2018 Aug; 34(5):512-517. PubMed ID: 28679331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.
    Dubé P; Sideris L; Law C; Mack L; Haase E; Giacomantonio C; Govindarajan A; Krzyzanowska MK; Major P; McConnell Y; Temple W; Younan R; McCart JA
    Curr Oncol; 2015 Apr; 22(2):e100-12. PubMed ID: 25908915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases.
    Narasimhan V; Das A; Warrier S; Lynch C; McCormick J; Tie J; Michael M; Ramsay R; Heriot A
    Langenbecks Arch Surg; 2019 Aug; 404(5):527-539. PubMed ID: 31377856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment principles for peritoneal surface malignancies.
    Deraco M; Kusamura S; Corbellini C; Guaglio M; Paviglianiti C; Baratti D
    Minerva Chir; 2016 Apr; 71(2):124-45. PubMed ID: 26847729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Italian Society of Surgical Oncology (SICO) survey on the minimum requirements of rare cancers referral centers.
    Gronchi A; Delrio P; Quagliuolo V; Sandrucci S
    Updates Surg; 2016 Dec; 68(4):321-323. PubMed ID: 27312931
    [No Abstract]   [Full Text] [Related]  

  • 9. The italian society of surgical oncology (SICO).
    Moggi L; Badellino F; Giustozzi G; Bufalari A; Gipponi M; Sensi B
    J Surg Oncol; 2000 May; 74(1):1. PubMed ID: 10861599
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Peritoneal Surface Malignancies with Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC): Experience in Israel.
    Ben-Yaacov A; Nizri E; Lahat G; Berger Y; Sadot E; Lavi R; Zippel D; Sebbag G; Avital I; Hoffman A; Gutman M; Halevy A; Schneibaum S; Ben-Ari G; Benchimol D; Klausner J; Nissan A;
    Indian J Surg Oncol; 2019 Feb; 10(Suppl 1):19-23. PubMed ID: 30886488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology.
    Sommariva A; Ansaloni L; Baiocchi GL; Cascinu S; Cirocchi R; Coccolini F; Deraco M; Fiorentini G; Gelmini R; Di Giorgio A; Lippolis PV; Pasqual EM; Sassaroli C; Macrì A; Sammartino P; Scaringi S; Valle M; Vaira M
    Eur J Surg Oncol; 2021 Jan; 47(1):164-171. PubMed ID: 33028502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paul Sugarbaker and Peritoneal Surface Oncology in India.
    Bhatt A; Mehta S; Ramakrishnan AS; Somashekhar SP; Deo SVS; Gopinath KS; Sethna K
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):5-6. PubMed ID: 37359932
    [No Abstract]   [Full Text] [Related]  

  • 13. Peritoneal metastases: challenges for the surgeon.
    Baratti D; Kusamura S; Guaglio M; Deraco M
    Minerva Chir; 2015 Jun; 70(3):195-215. PubMed ID: 25752673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status of Peritoneal Surface Malignancy in Thailand.
    Sirisai C; Methasate A
    Indian J Surg Oncol; 2019 Feb; 10(Suppl 1):29-32. PubMed ID: 30886490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes.
    Mielko J; Rawicz-Pruszyński K; Sędłak K; Gęca K; Kwietniewska M; Polkowski WP
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32842535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camera-port site metastasis of a renal-cell carcinoma after robot-assisted partial nephrectomy.
    Song JB; Tanagho YS; Kim EH; Abbosh PH; Vemana G; Figenshau RS
    J Endourol; 2013 Jun; 27(6):732-9. PubMed ID: 23297710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Italian version of the LARS score: cross-cultural adaptation and validation. An Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CCN) collaborative study.
    Resendiz A; Martini G; Sensi B; Reddavid R; Marchiori G; Franco C; Franceschilli M; Imperio N; Sica G; Spolverato G; Degiuli M
    Int J Colorectal Dis; 2021 Aug; 36(8):1805-1810. PubMed ID: 33709162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical Management of Peritoneal Surface Malignancy with Respect to Tumour Type, Tumour Stage and Individual Tumour Biology].
    Beckert S; Struller F; Grischke EM; Glatzle J; Zieker D; Königsrainer A; Königsrainer I
    Zentralbl Chir; 2016 Aug; 141(4):415-20. PubMed ID: 24241953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future.
    Nissan A; Stojadinovic A; Garofalo A; Esquivel J; Piso P
    J Surg Oncol; 2009 Sep; 100(4):335-44. PubMed ID: 19697442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis.
    Nunez MF; Sardi A; Jimenez W; Nieroda C; Sittig M; MacDonald R; Aydin N; Milovanov V; Gushchin V
    Ann Surg Oncol; 2015 Apr; 22(4):1267-73. PubMed ID: 25319578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.